OCMS Bio
Founded 2017
About OCMS Bio
OCMS Bio® is a company that develops monoclonal antibody discovery tools. On-Cell mAb Screening is a proprietary technology that greatly accelerates antibody discovery. OCMS® fluorescent imaging methods revolutionize mAb discovery from patient-derived antibodies, transgenic mouse models, and AI antibody engineering. AI-driven pandemic prevention is a major focus of our internal research program.
Company Facts
- Founded: 2017
- Legal name: OCMS Bio®, LLC.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Website: ocms.bio
- Phone: +1 678 626 7246
Social Profiles
Canonical: https://fsome.com/organization/ocms-bio-8355571 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.